Trading Signals: CYDY Stock Price Prediction and Forecast (Tue. Jul. 21, 2020 - Tue. Feb. 14, 2023)(CytoDyn Inc. )
| CYDY latest price $5.5500 (7.98%) ($5.1000 - $5.6300) on Fri. Jan. 29, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 15.37% (three month average) | RSI | 0 | Latest Price | $5.5500(7.98%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CYDY advances 2.8% a day on average for past five trading days. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support CYDY advance at 0% a week (0% probability) XBI(64%) XLRE(90%) XLV(86%) XLP(56%) XLY(56%) | Factors Impacting CYDY price | CYDY will decline at least -7.685% in a week (0% probabilities). XRT(-8%) LIT(10%) IDRV(-7%) JETS(-2%) IWO(14%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -7.685% (StdDev 15.37%) | Hourly BBV | 0 () | Intraday Trend | 8% | | | |
|
5 Day Moving Average | $5.11(8.61%) | 10 Day Moving Average | $5.11(8.61%) | 20 Day Moving Average | $4.84(14.67%) | To recent high | -6.4% | To recent low | 8% | Market Cap | $2.88b | | | | CytoDyn, Inc. is a clinical-stage biotechnology company, which engages in the development of innovative treatments for multiple therapeutic indications based on leronlimab. Its product include HIV, cancer, graft-versus-host disease (GVHD), and PCa test. The company was founded by Allen D. Allen on May 2, 2002 and is headquartered in Vancouver, WA. |